Tesaro

4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
biotech
M&A
Gilead Sciences
Sanofi
Medivation
Incyte
Biomarin
Tesaro
Seattle Genetics
An Overnight Double! Could These Drugmakers Be Next?
Motley Fool
Sat, 07/2/16 - 12:36 pm
Tesaro
ovarian cancer
PARP inhibitors
niraparib
AstraZeneca
Lynparza
Medivation
AbbVie
Clovis Oncology
This Biotech's Stock Just Doubled and It's Bad News for Sanofi
Fortune
Thu, 06/30/16 - 09:27 am
Tesaro
Sanofi
ovarian cancer
niraparib
Medivation
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Tesaro Shares Surge 82% Because Drug Slows Ovarian Cancer
Forbes
Wed, 06/29/16 - 10:51 am
Tesaro
ovarian cancer
niraparib
clinical trials
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
Fierce Biotech
Wed, 04/6/16 - 09:51 am
JNJ
prostate cancer
Tesaro
niraparib
FDA approves Tesaro's drug for chemotherapy-induced nausea
Yahoo/Reuters
Wed, 09/2/15 - 10:23 am
FDA
Tesaro
chemotherapy-induced nausea and vomiting
Varubi
rolapitant
5 Big FDA Decisions Expected in September
24/7 Wall St
Sun, 08/30/15 - 02:08 pm
FDA
rolapitant
OPKO Health
Tesaro
Zosano
ZP-Glucagon
XenoPort
XP23829
Apricus Biosciences
RayVa
Tesaro reports 1Q loss
Yahoo/AP
Fri, 05/1/15 - 09:54 am
Tesaro
earnings
Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Yahoo/Benzinga
Fri, 01/30/15 - 02:34 pm
Novartis
Celgene
Pharmacyclics
EXACT Sciences
Tesaro
Foundation Medicine
Bind Therapeutics
Kite Pharma
Celldex Therapeutics
Should You Believe Tesaro's Hype?
Motley Fool
Mon, 03/17/14 - 05:00 pm
Tesaro
rolapitant
AnaptysBio
cancer immunotherapy
Tesaro pays $17M to team with AnaptysBio on cancer immunotherapies
Fierce Biotech
Thu, 03/13/14 - 08:34 am
Tesaro
AnaptysBio
cancer immunotherapy
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Ignyta
oncology
Clovis Oncology
Ariad Pharmaceuticals
Mirati Therapeutics
Tesaro
Puma Biotechnology
[video] Tesaro: Next big thing in biotech?
CNBC
Tue, 01/14/14 - 08:11 am
Tesaro
rolapitant
chemotherapy-induced nausea and vomiting
Tesaro nausea drug effective in late-stage trials
Reuters
Mon, 12/23/13 - 11:00 am
Tesaro
rolapitant
chemotherapy-induced nausea and vomiting
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:35 pm
TSR-011
pancreatic cancer
Tesaro
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 06/8/13 - 10:15 am
Clovis Oncology
Tesaro
Acadia
Allergan
Scrappy Upstarts Aiming For Pfizer's Xalkori Market
Seeking Alpha
Mon, 06/3/13 - 11:29 am
Pfizer
Xalkori
Tesaro
Ariad Pharmaceuticals
AP26113
lung cancer
TSR-011

Pages